• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构洞察配体识别和激活中链脂肪酸感应受体 GPR84。

Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84.

机构信息

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, 310024, Hangzhou, China.

出版信息

Nat Commun. 2023 Jun 6;14(1):3271. doi: 10.1038/s41467-023-38985-6.

DOI:10.1038/s41467-023-38985-6
PMID:37277332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10241960/
Abstract

GPR84 is an orphan class A G protein-coupled receptor (GPCR) that is predominantly expressed in immune cells and plays important roles in inflammation, fibrosis, and metabolism. Here, we present cryo-electron microscopy (cryo-EM) structures of Gα protein-coupled human GPR84 bound to a synthetic lipid-mimetic ligand, LY237, or a putative endogenous ligand, a medium-chain fatty acid (MCFA) 3-hydroxy lauric acid (3-OH-C12). Analysis of these two ligand-bound structures reveals a unique hydrophobic nonane tail -contacting patch, which forms a blocking wall to select MCFA-like agonists with the correct length. We also identify the structural features in GPR84 that coordinate the polar ends of LY237 and 3-OH-C12, including the interactions with the positively charged side chain of R172 and the downward movement of the extracellular loop 2 (ECL2). Together with molecular dynamics simulations and functional data, our structures reveal that ECL2 not only contributes to direct ligand binding, but also plays a pivotal role in ligand entry from the extracellular milieu. These insights into the structure and function of GPR84 could improve our understanding of ligand recognition, receptor activation, and Gα-coupling of GPR84. Our structures could also facilitate rational drug discovery against inflammation and metabolic disorders targeting GPR84.

摘要

GPR84 是一种孤儿 A 类 G 蛋白偶联受体 (GPCR),主要在免疫细胞中表达,在炎症、纤维化和代谢中发挥重要作用。在这里,我们呈现了与人 GPR84 结合的 G 蛋白偶联的冷冻电镜 (cryo-EM) 结构,这些 GPR84 结合了合成的脂质模拟配体 LY237 或假定的内源性配体中链脂肪酸 (MCFA) 3-羟基月桂酸 (3-OH-C12)。对这两种配体结合结构的分析揭示了一个独特的疏水性非烷烃尾部接触斑块,它形成了一个阻挡壁,以选择具有正确长度的 MCFA 样激动剂。我们还确定了 GPR84 中与 LY237 和 3-OH-C12 的极性末端协调的结构特征,包括与 R172 的正电荷侧链的相互作用和细胞外环 2 (ECL2) 的向下移动。结合分子动力学模拟和功能数据,我们的结构表明,ECL2 不仅有助于直接配体结合,而且在配体从细胞外环境进入受体中也起着关键作用。这些关于 GPR84 的结构和功能的见解可以提高我们对配体识别、受体激活和 GPR84 的 Gα 偶联的理解。我们的结构也可以促进针对 GPR84 的炎症和代谢紊乱的合理药物发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/ab8c8ca96354/41467_2023_38985_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/c89262619d90/41467_2023_38985_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/8b4a66c2b3bb/41467_2023_38985_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/de7097162d33/41467_2023_38985_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/9ab2327430e1/41467_2023_38985_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/972ed47d2c28/41467_2023_38985_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/ab8c8ca96354/41467_2023_38985_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/c89262619d90/41467_2023_38985_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/8b4a66c2b3bb/41467_2023_38985_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/de7097162d33/41467_2023_38985_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/9ab2327430e1/41467_2023_38985_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/972ed47d2c28/41467_2023_38985_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71f/10241960/ab8c8ca96354/41467_2023_38985_Fig6_HTML.jpg

相似文献

1
Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84.结构洞察配体识别和激活中链脂肪酸感应受体 GPR84。
Nat Commun. 2023 Jun 6;14(1):3271. doi: 10.1038/s41467-023-38985-6.
2
20 Years an Orphan: Is GPR84 a Plausible Medium-Chain Fatty Acid-Sensing Receptor?20 年的孤儿:GPR84 是否是一种合理的中链脂肪酸感应受体?
DNA Cell Biol. 2020 Nov;39(11):1926-1937. doi: 10.1089/dna.2020.5846. Epub 2020 Oct 1.
3
Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84.中链脂肪酸通过免疫调节受体 GPR84 抑制脂毒性诱导的肝纤维化。
JCI Insight. 2023 Jan 24;8(2):e165469. doi: 10.1172/jci.insight.165469.
4
Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R.中链脂肪酸受体 GPR84 和短链脂肪酸受体 FFA2R 激活诱导人吞噬细胞产生的反应的异同。
Biochim Biophys Acta Mol Cell Res. 2018 May;1865(5):695-708. doi: 10.1016/j.bbamcr.2018.02.008. Epub 2018 Feb 22.
5
Structure-Activity Relationship Studies and Optimization of 4-Hydroxypyridones as GPR84 Agonists.4-羟基吡啶酮类作为 GPR84 激动剂的构效关系研究与优化。
J Med Chem. 2024 Mar 14;67(5):3542-3570. doi: 10.1021/acs.jmedchem.3c01923. Epub 2024 Feb 21.
6
Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84.孤儿 G 蛋白偶联受体的治疗验证:以 GPR84 为例。
Br J Pharmacol. 2022 Jul;179(14):3529-3541. doi: 10.1111/bph.15248. Epub 2020 Sep 17.
7
Pro-phagocytic function and structural basis of GPR84 signaling.GPR84 信号的促吞噬作用功能和结构基础。
Nat Commun. 2023 Sep 14;14(1):5706. doi: 10.1038/s41467-023-41201-0.
8
Biased agonists of GPR84 and insights into biological control.GPR84 的偏倚激动剂及对生物调控的启示。
Br J Pharmacol. 2024 May;181(10):1509-1523. doi: 10.1111/bph.16310. Epub 2024 Jan 23.
9
GPR84 in physiology-Many functions in many tissues.GPR84 在生理学中的作用——在多种组织中具有多种功能。
Br J Pharmacol. 2024 May;181(10):1524-1535. doi: 10.1111/bph.16206. Epub 2023 Aug 28.
10
Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets.GPR84 缺失对给予长链或中链脂肪酸丰富饮食的肥胖和糖尿病发展的影响。
Eur J Nutr. 2018 Aug;57(5):1737-1746. doi: 10.1007/s00394-017-1456-5. Epub 2017 Apr 20.

引用本文的文献

1
Comprehensive multi-omics analysis reveals the core role of glycerophospholipid metabolism in the influence of short-chain fatty acids on the development of sepsis.综合多组学分析揭示甘油磷脂代谢在短链脂肪酸对脓毒症发展影响中的核心作用。
Sci Rep. 2025 Aug 9;15(1):29164. doi: 10.1038/s41598-025-13322-7.
2
Steric control of signaling bias in the immunometabolic receptor GPR84.免疫代谢受体GPR84中信号偏向的空间控制
bioRxiv. 2025 Aug 2:2025.07.30.667614. doi: 10.1101/2025.07.30.667614.
3
An update for AlphaFold3 versus experimental structures: assessing the precision of small molecule binding in GPCRs.

本文引用的文献

1
Structure of the active G-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist.活性 G 偶联人溶血磷脂酸受体 1 与有效激动剂复合物的结构。
Nat Commun. 2022 Sep 15;13(1):5417. doi: 10.1038/s41467-022-33121-2.
2
Structural identification of lysophosphatidylcholines as activating ligands for orphan receptor GPR119.鉴定溶血磷脂酰胆碱为孤儿受体 GPR119 的激活配体。
Nat Struct Mol Biol. 2022 Sep;29(9):863-870. doi: 10.1038/s41594-022-00816-5. Epub 2022 Aug 15.
3
Investigating the Structure-Activity Relationship of 1,2,4-Triazine G-Protein-Coupled Receptor 84 (GPR84) Antagonists.
AlphaFold3与实验结构的更新:评估GPCR中小分子结合的精度。
Acta Pharmacol Sin. 2025 Jul 9. doi: 10.1038/s41401-025-01617-4.
4
Targeting GPR84 to alleviate acute immune-mediated liver injury.靶向GPR84以减轻急性免疫介导的肝损伤。
Mol Med. 2025 May 14;31(1):187. doi: 10.1186/s10020-025-01248-9.
5
G-Protein-Coupled Receptor 84 Aggravates Early Brain Injury via Microglial NLRP3-ASC Inflammasome After Subarachnoid Hemorrhage.G蛋白偶联受体84在蛛网膜下腔出血后通过小胶质细胞NLRP3-ASC炎性小体加重早期脑损伤。
Brain Behav. 2025 Apr;15(4):e70379. doi: 10.1002/brb3.70379.
6
Structural basis of the cysteinyl leukotriene receptor type 2 activation by LTD4.白三烯D4激活半胱氨酰白三烯受体2型的结构基础
Proc Natl Acad Sci U S A. 2025 Apr 15;122(15):e2417148122. doi: 10.1073/pnas.2417148122. Epub 2025 Apr 7.
7
Cryo-EM Structures and AlphaFold3 Models of Histamine Receptors Reveal Diverse Ligand Binding and G Protein Bias.组胺受体的冷冻电镜结构和AlphaFold3模型揭示了不同的配体结合和G蛋白偏向性。
Pharmaceuticals (Basel). 2025 Feb 21;18(3):292. doi: 10.3390/ph18030292.
8
The structural basis of the G protein-coupled receptor and ion channel axis.G蛋白偶联受体与离子通道轴的结构基础。
Curr Res Struct Biol. 2025 Feb 18;9:100165. doi: 10.1016/j.crstbi.2025.100165. eCollection 2025 Jun.
9
Maternal consumption of glycerol monolaurate optimizes milk fatty acid profile and enhances piglet gut health in association with G protein-coupled receptor 84 (GPR84) activation.母体摄入月桂酸单甘油酯可优化乳脂肪酸谱,并通过激活G蛋白偶联受体84(GPR84)增强仔猪肠道健康。
Anim Nutr. 2024 Dec 31;20:387-403. doi: 10.1016/j.aninu.2024.11.017. eCollection 2025 Mar.
10
GPCR drug discovery: new agents, targets and indications.G蛋白偶联受体药物研发:新型药物、靶点与适应症
Nat Rev Drug Discov. 2025 Mar 3. doi: 10.1038/s41573-025-01139-y.
研究 1,2,4-三嗪 G 蛋白偶联受体 84(GPR84)拮抗剂的构效关系。
J Med Chem. 2022 Aug 25;65(16):11270-11290. doi: 10.1021/acs.jmedchem.2c00804. Epub 2022 Aug 10.
4
Structural insights into sphingosine-1-phosphate receptor activation.结构洞察神经鞘氨醇-1-磷酸受体的激活。
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2117716119. doi: 10.1073/pnas.2117716119. Epub 2022 Apr 11.
5
Molecular basis for allosteric agonism and G protein subtype selectivity of galanin receptors.Galanin 受体变构激动作用和 G 蛋白亚型选择性的分子基础。
Nat Commun. 2022 Mar 15;13(1):1364. doi: 10.1038/s41467-022-29072-3.
6
Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2.甲酰肽受体 FPR1 和 FPR2 对甲酰肽和多种激动剂的分子识别。
Nat Commun. 2022 Feb 25;13(1):1054. doi: 10.1038/s41467-022-28586-0.
7
Phosphodiesters as GPR84 Antagonists for the Treatment of Ulcerative Colitis.磷酸二酯酶作为 GPR84 拮抗剂用于溃疡性结肠炎的治疗。
J Med Chem. 2022 Mar 10;65(5):3991-4006. doi: 10.1021/acs.jmedchem.1c01813. Epub 2022 Feb 23.
8
Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate.溶血磷脂酸和鞘氨醇 1-磷酸对脂质 GPCR 的差异化激活机制。
Nat Commun. 2022 Feb 8;13(1):731. doi: 10.1038/s41467-022-28417-2.
9
Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.A类脂质G蛋白偶联受体的结构、功能与药理学研究进展:药物研发的机遇与挑战
Pharmaceuticals (Basel). 2021 Dec 22;15(1):12. doi: 10.3390/ph15010012.
10
Structural basis of sphingosine-1-phosphate receptor 1 activation and biased agonism.1-磷酸鞘氨醇受体1激活及偏向性激动作用的结构基础
Nat Chem Biol. 2022 Mar;18(3):281-288. doi: 10.1038/s41589-021-00930-3. Epub 2021 Dec 22.